| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |